Search results

1 – 10 of 180
Expert briefing
Publication date: 4 July 2018

Contribution of healthcare sector to Greece’s recovery.

Expert briefing
Publication date: 4 November 2015

Outlook for pharmaceutical markets in sub-Saharan Africa.

Details

DOI: 10.1108/OXAN-DB206409

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 26 February 2016

The risks of liberalising the pharmaceuticals market.

Expert briefing
Publication date: 9 June 2015

The Russian pharmaceuticals sector.

Details

DOI: 10.1108/OXAN-DB200128

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 4 June 2020

Russia has a thriving pharmaceutical sector, but companies are struggling to meet the surge in demand for a range of essential drugs. The obstacles come from new supply-chain…

Details

DOI: 10.1108/OXAN-DB253011

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 25 September 2020

Public health structures were developed and expanded over four decades of war and isolation, allowing them to mobilise effectively against COVID-19 despite the negative impacts of…

Details

DOI: 10.1108/OXAN-DB256488

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 15 May 2018

The consensus among most economists is that whatever the eventual deal, the United Kingdom will be worse off in the long run as a result of leaving the EU. However, the economic…

Details

DOI: 10.1108/OXAN-DB233768

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 14 October 2020

Initial data are expected to become available before the end of the year, and subject to evidence of safety and efficacy, to be submitted for approval and fast-tracked so that a…

Details

DOI: 10.1108/OXAN-DB256851

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 5 February 2021

The vaccine is one of four being developed by Cuba, which aims to become a key international vaccine supplier, to enhance the strategic and economic impacts of its health…

Expert briefing
Publication date: 20 November 2020

Diversion from legitimate pharmaceutical stocks, counterfeiting, adulteration and false labelling are key problems. National and international responses emphasising stricter…

1 – 10 of 180